Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KC Rising red flag: Educated talent leaving KC, metro tech jobs unfilled
More college-educated workers are leaving Kansas City than being drawn to the region, according to a new KC Rising report. That means local companies are forced to look outward for qualified talent, said Ryan Weber. “Most of those tech firms are hiring; it’s just for skill sets that few people have,” said Weber, president of…
Students struck by KC gun violence search for solutions at MECA Challenge
Editor’s note: MECA Challenge and Startland News are both programs of the Kansas City Startup Foundation, though the content below was produced independently by Startland. For more information on the relationship, click here. Escaping the cycle of gun violence can seem impossible, said Lea Thompson, still wearing a cast on her hand after being shot…
STEAM Studio team coding best fit for boy’s 3-D-printed prosthetic arm
Four-year-old Hudson Borton extended his arm Wednesday, as his father fitted a 3-D-printed prosthetic to the boy’s upper arm and elbow. The light blue plastic piece mimicked the size and length of Hudson’s right arm, though his father and Mandi Sonnenberg, co-founder and director of STEAM Studio, agreed the new device wasn’t yet a perfect…
KC-based SouveNEAR vending machine startup prepping to scale up
SouveNEAR offers travelers a piece of KC — from KC, said co-founder Tiffany King. The Kansas City-based startup, which repurposes vending machines to sell locally made souvenirs, is in its fourth year of steady, organic growth, King said. As a member of ScaleUP! KC new class, SouveNEAR is preparing to grow the business and turn…